Saturday, June 13, 2020 1:11:39 AM
Weekly Review June 08-12;
Mon;
Tue;
Wen;
Thur;
Fri;
Fri 06-05= .0072
Fri 03-12= .0072= 0%
We wait.
Imagine if you will,
a 24mil float that's been lagging under the radar,
as the 24mil float gets even more locked the longer this drags out.
Imagine everybody wants in yet,
no one is selling.
Imagine a no ask.
Cheers
Mon;
Tue;
Wen;
Thur;
Fri;
Fri 06-05= .0072
Fri 03-12= .0072= 0%
We wait.
Imagine if you will,
a 24mil float that's been lagging under the radar,
as the 24mil float gets even more locked the longer this drags out.
Imagine everybody wants in yet,
no one is selling.
Imagine a no ask.
Cheers
Recent CSDX News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 07:54:26 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 10:02:11 AM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 03/12/2026 04:05:23 PM
- CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH • GlobeNewswire Inc. • 02/11/2026 03:01:57 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 07:00:11 PM
- CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products • GlobeNewswire Inc. • 01/29/2026 01:49:13 PM
- CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP • GlobeNewswire Inc. • 01/21/2026 03:22:05 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 11/17/2025 01:57:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 08:06:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 06:11:22 PM
- CS Interpharm and CS Diagnostics Pharma Complete Conversion of Preferred Shares to Common Stock, Strengthening CSDX's Path to Consolidated Financial Reporting • ACCESS Newswire • 10/31/2025 03:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/09/2025 08:21:28 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 09/09/2025 10:01:49 AM
- Form 10-12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 07/29/2025 07:06:35 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 07/24/2025 08:15:15 PM
- Form 10-12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 07/22/2025 12:47:53 PM

